Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

MGRX Mangoceuticals Inc

2,37

-0,08 (-3,27%)

01 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

06/18/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Alex P. Hamilton

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Mangoceuticals (NASDAQ:MGRX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Mangoceuticals Charts.

Mangoceuticals (NASDAQ:MGRX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Mangoceuticals Charts.

News Mangoceuticals Inc

Form 8-K - Current report
Donnerstag 26 Dezember 2024 (6 Tage vor) • Edgar (US Regulatory)

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
Donnerstag 19 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 19 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 6 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
Mittwoch 4 Dezember 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 31 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Donnerstag 31 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 25 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 22 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

MangoRx Announces Formation of Strategy and Alternatives Committee
Dienstag 22 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Mangoceuticals Inc News-Artikel

Deutsche Lufthansa

Energy Select Sector SPDR

Euro vs US Dollar

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen